entity

ITE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ITE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

6Connections

30Hypotheses

0Analyses

6Outgoing

0Incoming

7Experiments

0Debates

No AI portrait yet

Wiki Pages (2)

Knowledge base pages for this entity

ALSENLITE: Senolytics for Alzheimer's Disease Trial

treatment · 1194 words

→

ALSENLITE: Senolytics Trial for AD (NCT04785300)

clinical · 829 words

→

Outgoing (6)

Target	Relation	Type	Str
AhR	activates	protein	0.92
Retinal Local Inflammation	downregulates	process	0.90
Retinal Ganglion Cell Apoptosis	protects_against	process	0.90
Retinal Local Inflammation	downregulates	process	0.85
Retinal Ischemia/Reperfusion Injury	treats	disease	0.85
ERK	inhibits	protein	0.85

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Multi-Biomarker Composite Index Surpassing Amyloid PET for T	0.933	neurodegeneration	What amyloid threshold level is required
ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drive	0.801	Alzheimer's Disease	Cell type vulnerability in Alzheimers Di
ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligo	0.779	Alzheimer's Disease	Cell type vulnerability in Alzheimers Di
Oligodendrocyte Precursor Cell Senescence in White Matter Di	0.769	-	Senescent cell clearance as neurodegener
Loss of AQP4 Polarization Impairs Glymphatic Perivascular In	0.690	neurodegeneration	What are the specific molecular mechanis

Time-Limited AQP4 Inhibition for Acute Cytotoxic Edema Follo	0.690	neurodegeneration	How can AQP4 be effectively targeted the
STMN2 Restoration as a Prerequisite for Axon Growth After TD	0.683	neurodegeneration	What molecular mechanisms enable functio
White Matter Oligodendrocyte Protection via CXCL10 Inhibitio	0.675	neurodegeneration	Gene expression changes in aging mouse b
Mitochondrial-Lysosomal Contact Site Engineering	0.668	neurodegeneration	Autophagy-lysosome pathway convergence a
White Matter Vulnerability Prevention via Oligodendrocyte Pr	0.667	neurodegeneration	Gene expression changes in aging mouse b
RNA Granule Nucleation Site Modulation	0.662	neurodegeneration	TDP-43 phase separation therapeutics for
Oligodendrocyte White Matter Vulnerability	0.651	neurodegeneration	Gene expression changes in aging mouse b
TREM2-Mediated Oligodendrocyte-Microglia Metabolic Coupling	0.649	neurodegeneration	Gene expression changes in aging mouse b
CLU-APOE-TREM2 Tripartite Axis as a Coordinate Therapeutic T	0.648	neurodegeneration	Does clusterin exacerbate or protect aga
White Matter Immune Checkpoint Restoration	0.644	neurodegeneration	Gene expression changes in aging mouse b
Cross-Cell Type Synaptic Rescue via Tripartite Synapse Resto	0.620	neurodegeneration	Cell type vulnerability in Alzheimer's D
Neurovascular Permeability Score (NVPS): Composite Plasma +	0.600	-	Blood-brain barrier permeability changes
TREM2-Mediated Oligodendrocyte-Microglia Cross-talk in White	0.600	neurodegeneration	Gene expression changes in aging mouse b
OPC differentiation blockade contributes to white matter deg	0.599	Alzheimer's disease	SEA-AD Single-Cell Analysis: Cell-Type V
Aryl Hydrocarbon Receptor (AhR) Activation by Microbiome Met	0.591	neuroinflammation	What molecular mechanisms determine whet
TREM2-Mediated Oligodendrocyte-Microglia Signaling in White	0.587	neurodegeneration	Gene expression changes in aging mouse b
Limited Calcium Release Without Sufficient Cathepsin Efflux	0.580	neurodegeneration	How does controlled lysosomal membrane p
NAC + Ferrostatin-1 Combination for Peroxynitrite-Ferroptosi	0.530	neurodegeneration	Can ferroptosis inhibitors prevent BBB d
Microbial Metabolite-Mediated α-Synuclein Disaggregation	0.511	neurodegeneration	What are the mechanisms by which gut mic
Tripartite Synapse Cell Type-Nonautonomous Crosstalk: Coordi	0.510	neurodegeneration	Cell type vulnerability debate in Alzhei
OPA1-Mediated Cristae Architecture Vulnerability	0.490	neurodegeneration	What determines the specificity of TDP-4
Microbiome-Derived Tryptophan Metabolite Neuroprotection	0.427	neurodegeneration	What are the mechanisms by which gut mic
HDAC2-Specific Repression of PU.1 Pioneer Factor Target Site	0.415	neurodegeneration	How does HDAC1/2 deletion specifically e
A-to-I RNA editing modulates the lncRNA-0021 binding site an	0.390	molecular neurobiology	How does lncRNA-0021 achieve sequence-sp
Blood-Brain Barrier Metabolite Transporter Enhancement for D	0.220	metabolomics	Metabolomic signatures of neurodegenerat

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (7)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
SIRPα modulation in mouse models of Alzheimer's disease	validation	Alzheimer's disease	0.900	0.00	mouse models of Alzheimer's di	proposed	N/A
CXCL10 biomarker analysis for CPSP prediction	clinical	chronic postsurgical pain	0.900	0.00	human patients undergoing thor	proposed	N/A
Microglial SIRPα expression in human Alzheimer's disease tissue	exploratory	Alzheimer's disease	0.800	0.00	human brain tissue	proposed	N/A
E2F coordination of G2/M transcriptional program	exploratory		0.750	0.00	endocycling mammalian cells	proposed	N/A
Validate Mitochondria-Lysosome Contact Site Dysfunction in PD	validation	Parkinson's Disease	0.400	0.50	human	proposed	$2,730,000
MLCS Quantification in Parkinson's Disease	validation	Parkinson's Disease	0.400	0.50	human	proposed	$2,730,000
TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism and Therapeu	validation	Neurodegeneration	0.400	0.50	human	proposed	$2,730,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Lactate accumulation drives hepatocellular carcinoma metastasis through facilita [PMID:40120799]	Jiang C, He X, Chen X, Huang J, Liu Y, Z	Cancer Lett	2025	1
TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signa [PMID:32972302]	Zhou C, Liang Y, Zhou L, Yan Y, Liu N, Z	Autophagy	2021	1
Role of the endolysosomal pathway and exosome release in tau propagation. [PMID:33582164]	Yan M, Zheng T	Neurochem Int	2021	1
Rab7a and Mitophagosome Formation. [PMID:30857122]	Tan EHN, Tang BL	Cells	2019	1
Unveiling the choroidal immune landscape revealed interferon-gamma and TNF-alpha [PMID:41077603]	Ye L, Zhao T, Tian H, Li R, Li Z et al.	Sci China Life Sci	2026	0
METTL3/CXCL10 axis contributes to renal fibrosis by promoting the apoptosis of t [PMID:41138934]	Sun Y, Ren Z, Ge J, Zhang W, Shao F et a	Biochim Biophys Acta Mol Basis	2026	0
The mechanism of Qing-Fei-Yin decoction against influenza: Synergistical inhibit [PMID:41317805]	Nie W, Wang M, Cheng M, Ren Z, Liu G et	J Ethnopharmacol	2026	0
IL-25-ILC2-IL-13 axis improves traumatic brain injury by mediating CXCL-10-depen [PMID:41527095]	Peng M, Shu D, Chen Z, Yang Z, Zhang M e	J Neuroinflammation	2026	0
Oligodendrocyte transcription factor 2 orchestrates glioblastoma immune evasion [PMID:41591814]	Zhang X, Xue J, Zhao C, Zeng C, Zhong J	J Clin Invest	2026	0
Indole-3-propionic acid inhibits astrocyte inflammation and promotes motor funct [PMID:41663028]	Yu D, Kang J, Jiang W, Zhang C, Zhao X e	Neuropharmacology	2026	0
Cobrotoxin mitigates neuroinflammation and cognitive impairment by suppressing C [PMID:41671614]	Li Z, Tan B, Dong K, Yu X, Zhang SW et a	Biochem Pharmacol	2026	0
YY1 nitration participates in DbCM cardiomyocyte lipotoxicity by inhibiting ANXA [PMID:41702019]	Chai J, Han L, Mo D, Bai Y, Yang Y et al	Redox Biol	2026	0
Peripheral macrophages and T-cells accumulate in the degenerating optic tract af [PMID:41740873]	Main BS, Villapol S, Buenaventura RG, Ha	Brain Behav Immun	2026	0
Melanoma cell inoculation improves cognitive impairment in the 5xFAD mouse model [PMID:41760781]	Bruna-Jara B, More J, Lobos P, Ponce DP,	Scientific reports	2026	0
Microenvironment-educated MSC-EVs loaded injectable smart hydrogel for targeting [PMID:41799958]	Wu W, Cheng Z, Shi P, Gao H, Chen X et a	Bioact Mater	2026	0
Genetic Variation in the Chemokine Network and Atherosclerosis Risk. [PMID:41824188]	Zangas P, Georgakis MK	Curr Atheroscler Rep	2026	0
Chemokine-defined macrophage niches establish spatial organization of tumor immu [PMID:41872505]	Ghosh S, Li X, Rawat K, Dighal A, Kalino	Nat Immunol	2026	0
Agonists for cytosolic bacterial receptor ALPK1 induce antitumour immunity. [PMID:41372408]	Tian X, Liu J, Li Y, Wang Y, Luo Y, He H	Nature	2026	0
HTLV1-associated myelopathy as a translational model of progressive neurodegener [PMID:41926707]	da Silva MTT, Araujo AQC	Brain : a journal of neurology	2026	0
Bionanoconjugates in Neurodegeneration: Peptide-Nanoparticle Alliances for Next- [PMID:41199078]	["Ranjitha V", "Kumar A", "Kaalappa P"]	Pharmaceutical research	2025	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning ITE in their description or question text

Time-Limited AQP4 Inhibition for Acute Cytotoxic Edema Followed by Therapeutic R

Score: 0.690 · neurodegeneration · 2026-04-21

## **Molecular Mechanism and Rationale** Aquaporin-4 (AQP4) represents the predominant water channel in the central ner

STMN2 Restoration as a Prerequisite for Axon Growth After TDP-43 Clearance

Score: 0.683 · neurodegeneration · 2026-04-14

**Molecular Mechanism and Rationale** The molecular foundation of STMN2 restoration as a prerequisite for axonal regene

White Matter Oligodendrocyte Protection via CXCL10 Inhibition

Score: 0.675 · neurodegeneration · 2026-04-04

## Molecular Mechanism and Rationale The chemokine CXCL10 (C-X-C motif chemokine ligand 10), also known as interferon-γ

Mitochondrial-Lysosomal Contact Site Engineering

Score: 0.668 · neurodegeneration · 2026-04-02

## Mechanistic Overview Mitochondrial-Lysosomal Contact Site Engineering starts from the claim that modulating RAB7A wit

White Matter Vulnerability Prevention via Oligodendrocyte Protection

Score: 0.667 · neurodegeneration · 2026-04-04

## Mechanistic Overview White Matter Vulnerability Prevention via Oligodendrocyte Protection starts from the claim that

RNA Granule Nucleation Site Modulation

Score: 0.662 · neurodegeneration · 2026-04-02

## Mechanistic Overview RNA Granule Nucleation Site Modulation starts from the claim that modulating G3BP1 within the di

Oligodendrocyte White Matter Vulnerability

Score: 0.651 · neurodegeneration · 2026-04-02

## Mechanistic Overview Oligodendrocyte White Matter Vulnerability starts from the claim that modulating MOG within the

TREM2-Mediated Oligodendrocyte-Microglia Metabolic Coupling in White Matter Neur

Score: 0.649 · neurodegeneration · 2026-04-17

**Molecular Mechanism and Rationale** The TREM2-mediated oligodendrocyte-microglia metabolic coupling pathway represent

CLU-APOE-TREM2 Tripartite Axis as a Coordinate Therapeutic Target

Score: 0.648 · neurodegeneration · 2026-04-14

## Mechanistic Overview CLU-APOE-TREM2 Tripartite Axis as a Coordinate Therapeutic Target starts from the claim that mod

White Matter Immune Checkpoint Restoration

Score: 0.644 · neurodegeneration · 2026-04-04

## Mechanistic Overview White Matter Immune Checkpoint Restoration starts from the claim that modulating CXCL10 within t

Cross-Cell Type Synaptic Rescue via Tripartite Synapse Restoration

Score: 0.620 · neurodegeneration · 2026-04-04

## Mechanistic Overview Cross-Cell Type Synaptic Rescue via Tripartite Synapse Restoration starts from the claim that mo

Neurovascular Permeability Score (NVPS): Composite Plasma + Imaging Biomarker Pa

Score: 0.600 · unknown disease · 2026-04-26

A LASSO-optimized composite score integrating plasma GFAP, S100B, NFL, soluble PDGFR-β, and claudin-5 fragments to achie

TREM2-Mediated Oligodendrocyte-Microglia Cross-talk in White Matter Neurodegener

Score: 0.600 · neurodegeneration · 2026-04-21

## **Molecular Mechanism and Rationale** The TREM2 (Triggering Receptor Expressed on Myeloid cells 2) signaling pathway

OPC differentiation blockade contributes to white matter degeneration in early-s

Score: 0.599 · Alzheimer's disease · 2026-04-04

## Mechanistic Overview OPC differentiation blockade contributes to white matter degeneration in early-stage AD starts f

Aryl Hydrocarbon Receptor (AhR) Activation by Microbiome Metabolites Promotes A2

Score: 0.591 · neuroinflammation · 2026-04-14

## Mechanistic Overview Aryl Hydrocarbon Receptor (AhR) Activation by Microbiome Metabolites Promotes A2 Polarization st